Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS).

Hiroshi NakaseYuki HayashiDaisuke HirayamaTakayuki MatsumotoMinoru MatsuuraHideki IijimaKatsuyoshi MatsuokaNaoki OhmiyaShunji IshiharaFumihito HiraiDaiki AbukawaTadakazu Hisamatsunull null

Published in: Journal of gastroenterology (2022)

Age, BMI and steroid use were associated with COVID-19 severity in Japanese IBD patients.

Keyphrases

coronavirus disease
sars cov
patients with inflammatory bowel disease
ejection fraction
newly diagnosed
prognostic factors
body mass index
cross sectional
patient reported outcomes
double blind
ulcerative colitis